Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10142147
[patent_doc_number] => 09174944
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-11-03
[patent_title] => 'Crystalline lopinavir/surfactant adducts'
[patent_app_type] => utility
[patent_app_number] => 13/328121
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 8378
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13328121
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/328121 | Crystalline lopinavir/surfactant adducts | Dec 15, 2011 | Issued |
Array
(
[id] => 8140943
[patent_doc_number] => 20120095011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/313097
[patent_app_country] => US
[patent_app_date] => 2011-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23928
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20120095011.pdf
[firstpage_image] =>[orig_patent_app_number] => 13313097
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/313097 | NOVEL COMPOUNDS | Dec 6, 2011 | Abandoned |
Array
(
[id] => 9273604
[patent_doc_number] => 08637536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-28
[patent_title] => 'Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2'
[patent_app_type] => utility
[patent_app_number] => 13/310818
[patent_app_country] => US
[patent_app_date] => 2011-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79388
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13310818
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/310818 | Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2 | Dec 4, 2011 | Issued |
Array
(
[id] => 8228457
[patent_doc_number] => 20120142660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/309970
[patent_app_country] => US
[patent_app_date] => 2011-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15169
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13309970
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/309970 | AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS | Dec 1, 2011 | Abandoned |
Array
(
[id] => 8043475
[patent_doc_number] => 20120071480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => '4-(3-AMINOPYRAZOLE) PYRIMIDINE DERIVATIVES FOR USE AS TYROSINE KINASE INHIBITORS IN THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/308584
[patent_app_country] => US
[patent_app_date] => 2011-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29298
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071480.pdf
[firstpage_image] =>[orig_patent_app_number] => 13308584
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/308584 | 4-(3-AMINOPYRAZOLE) PYRIMIDINE DERIVATIVES FOR USE AS TYROSINE KINASE INHIBITORS IN THE TREATMENT OF CANCER | Nov 30, 2011 | Abandoned |
Array
(
[id] => 10831615
[patent_doc_number] => 08859784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Stereomerically pure fused bicyclic proline compounds useful for preparing hepatitis C protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/294930
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41393
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13294930
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/294930 | Stereomerically pure fused bicyclic proline compounds useful for preparing hepatitis C protease inhibitors | Nov 10, 2011 | Issued |
Array
(
[id] => 7808209
[patent_doc_number] => 20120059163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'Non-linear opticaly active molecules, their synthesis, and use'
[patent_app_type] => utility
[patent_app_number] => 13/290518
[patent_app_country] => US
[patent_app_date] => 2011-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14037
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20120059163.pdf
[firstpage_image] =>[orig_patent_app_number] => 13290518
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/290518 | Non-linear opticaly active molecules, their synthesis, and use | Nov 6, 2011 | Abandoned |
Array
(
[id] => 8056193
[patent_doc_number] => 20120077833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'ACID ADDITION SALTS OF (3,5-BIS TRIFLUOROMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3YL-PYRIMIDIN-2YLAMINO)-PHENYL]-BENZAMIDE'
[patent_app_type] => utility
[patent_app_number] => 13/289762
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3654
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077833.pdf
[firstpage_image] =>[orig_patent_app_number] => 13289762
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/289762 | Acid addition salts of (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide | Nov 3, 2011 | Issued |
Array
(
[id] => 10050743
[patent_doc_number] => 09090609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-28
[patent_title] => 'Benzyl-substituted carbamates and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/882123
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17792
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882123
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/882123 | Benzyl-substituted carbamates and use thereof | Nov 2, 2011 | Issued |
Array
(
[id] => 7783898
[patent_doc_number] => 20120045454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => '2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/288813
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 244673
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20120045454.pdf
[firstpage_image] =>[orig_patent_app_number] => 13288813
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/288813 | 2,4-pyrimidinediamine compounds and their uses | Nov 2, 2011 | Issued |
Array
(
[id] => 9582301
[patent_doc_number] => 08772304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'Benzimidazole inhibitors of leukotriene production'
[patent_app_type] => utility
[patent_app_number] => 13/281687
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12688
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13281687
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/281687 | Benzimidazole inhibitors of leukotriene production | Oct 25, 2011 | Issued |
Array
(
[id] => 7778557
[patent_doc_number] => 20120041001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'CARBONYLAMINO-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE'
[patent_app_type] => utility
[patent_app_number] => 13/280207
[patent_app_country] => US
[patent_app_date] => 2011-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16810
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041001.pdf
[firstpage_image] =>[orig_patent_app_number] => 13280207
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/280207 | Carbonylamino-derivatives as novel inhibitors of histone deacetylase | Oct 23, 2011 | Issued |
Array
(
[id] => 9009412
[patent_doc_number] => 08524710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Pyrrolidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/279364
[patent_app_country] => US
[patent_app_date] => 2011-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21077
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13279364
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/279364 | Pyrrolidine derivatives | Oct 23, 2011 | Issued |
Array
(
[id] => 7767951
[patent_doc_number] => 20120035151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'SUBSTITUTED DIHYDROPYRAZOLONES AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/271957
[patent_app_country] => US
[patent_app_date] => 2011-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20524
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035151.pdf
[firstpage_image] =>[orig_patent_app_number] => 13271957
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/271957 | Substituted dihydropyrazolones and their use | Oct 11, 2011 | Issued |
Array
(
[id] => 7757486
[patent_doc_number] => 20120029192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Pyrazole Derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/269278
[patent_app_country] => US
[patent_app_date] => 2011-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70139
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20120029192.pdf
[firstpage_image] =>[orig_patent_app_number] => 13269278
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/269278 | Pyrazole Derivatives | Oct 6, 2011 | Abandoned |
Array
(
[id] => 7744478
[patent_doc_number] => 20120022074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/252608
[patent_app_country] => US
[patent_app_date] => 2011-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6617
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022074.pdf
[firstpage_image] =>[orig_patent_app_number] => 13252608
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/252608 | Organic compounds | Oct 3, 2011 | Issued |
Array
(
[id] => 9232879
[patent_doc_number] => 08598183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Solid state forms of a potent HCV inhibitor'
[patent_app_type] => utility
[patent_app_number] => 13/241551
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18127
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13241551
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/241551 | Solid state forms of a potent HCV inhibitor | Sep 22, 2011 | Issued |
Array
(
[id] => 9757399
[patent_doc_number] => 20140288100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'GALACTOKINASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF ASSOCIATED DISEASES AND DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/346400
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9650
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346400
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346400 | Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders | Sep 22, 2011 | Issued |
Array
(
[id] => 10975453
[patent_doc_number] => 20140378488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => '4-SUBSTITUTED-(3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO)-PYRIMIDINE DERIVATIVES HAVING ACTIVITY OF INHIBITING PROTEIN KINASE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/342656
[patent_app_country] => US
[patent_app_date] => 2011-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24631
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342656
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/342656 | 4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof | Sep 4, 2011 | Issued |
Array
(
[id] => 8909486
[patent_doc_number] => 08481550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-09
[patent_title] => 'Heteroaryl compounds useful as inhibitors of E1 activating enzymes'
[patent_app_type] => utility
[patent_app_number] => 13/216352
[patent_app_country] => US
[patent_app_date] => 2011-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72942
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13216352
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/216352 | Heteroaryl compounds useful as inhibitors of E1 activating enzymes | Aug 23, 2011 | Issued |